LO RE, Oriana, C. FUSILLI, F. RAPPA, M. VAN HAELE, J. DOUET, J. PINDJAKOVA, S.W. ROCHA, I. PATA, Barbora VALČÍKOVÁ, Stjepan ULDRIJAN, R.S. YEUNG, C.A. PEIXOTO, T. ROSKAMS, M. BUSCHBECK, T. MAZZA a M. VINCIGUERRA. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma. Hepatology. Philadelphia: Saunders, roč. 67, č. 2, s. 636-650. ISSN 0270-9139. doi:10.1002/hep.29519. 2018.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
Autoři LO RE, Oriana (380 Itálie, domácí), C. FUSILLI (380 Itálie), F. RAPPA (380 Itálie), M. VAN HAELE (56 Belgie), J. DOUET (724 Španělsko), J. PINDJAKOVA (203 Česká republika), S.W. ROCHA (76 Brazílie), I. PATA (233 Estonsko), Barbora VALČÍKOVÁ (203 Česká republika, domácí), Stjepan ULDRIJAN (203 Česká republika, domácí), R.S. YEUNG (840 Spojené státy), C.A. PEIXOTO (76 Brazílie), T. ROSKAMS (56 Belgie), M. BUSCHBECK (724 Španělsko), T. MAZZA (380 Itálie) a M. VINCIGUERRA (826 Velká Británie a Severní Irsko, garant).
Vydání Hepatology, Philadelphia, Saunders, 2018, 0270-9139.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 14.971
Kód RIV RIV/00216224:14110/18:00102119
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1002/hep.29519
UT WoS 000422694900020
Klíčová slova anglicky histone variants; epigenetics; hepatocellular carcinoma; cancer stem cells
Štítky 14110513, EL OK, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 10. 2. 2019 14:50.
Anotace
Hepatocellular carcinomas (HCC) contain a subpopulation of cancer stem cells (CSCs), which exhibit stem cell-like features and are responsible for tumor relapse, metastasis, and chemoresistance. The development of effective treatments for HCC will depend on a molecular-level understanding of the specific pathways driving CSC emergence and stemness. MacroH2A1 is a variant of the histone H2A and an epigenetic regulator of stem-cell function, where it promotes differentiation and, conversely, acts as a barrier to somatic-cell reprogramming. Here, we focused on the role played by the histone variant macroH2A1 as a potential epigenetic factor promoting CSC differentiation. In human HCC sections we uncovered a significant correlation between low frequencies of macroH2A1 staining and advanced, aggressive HCC subtypes with poorly differentiated tumor phenotypes. Using HCC cell lines, we found that short hairpin RNA-mediated macroH2A1 knockdown induces acquisition of CSC-like features, including the growth of significantly larger and less differentiated tumors when injected into nude mice. MacroH2A1-depleted HCC cells also exhibited reduced proliferation, resistance to chemotherapeutic agents, and stem-like metabolic changes consistent with enhanced hypoxic responses and increased glycolysis. The loss of macroH2A1 increased expression of a panel of stemness-associated genes and drove hyperactivation of the nuclear factor kappa B p65 pathway. Blocking phosphorylation of nuclear factor kappa B p65 on Ser536 inhibited the emergence of CSC-like features in HCC cells knocked down for macroH2A1. Conclusion: The absence of histone variant macroH2A1 confers a CSC-like phenotype to HCC cells in vitro and in vivo that depends on Ser536 phosphorylation of nuclear factor kappa B p65; this pathway may hold valuable targets for the development of CSC-focused treatments for HCC.
VytisknoutZobrazeno: 23. 4. 2024 08:34